Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 2 Study of WGI-0301 for Advanced HCC | NCT06309485 | Zhejiang Haichang Biotech Co., Ltd. | user2@example.com | None | 2024-08-31 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors | NCT05267899 | Zhejiang Haichang Biotech Co., Ltd. | user2@example.com | None | 2022-08-01 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |